SCHEMBL3168952

SCHEMBL3168952

CC(=O)NCCNc1cc(NCCNC(=O)c2ccc(Br)c(C)c2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP1A2 P05177 2/20 0.42
GPR119 Q8TDV5 1/20 0.42
MALT1 Q9UDY8 1/20 0.41
GCG P01275 1/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
LCK P06239 2/20 0.41
S1PR1 P21453 2/20 0.40
S1PR3 Q99500 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3161208 0.90 CYP1A2 (0.47) ADORA3SMN1; SMN2CYP1A2GPR119ALDH1A1
SCHEMBL3161520 0.89 ALDH1A1 (0.45) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL3170845 0.87 ADORA3 (0.46) ADORA3MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL3163156 0.86 RAB9A (0.48) ADORA3MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL3176983 0.85 ADORA3 (0.57) ADORA3MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL3170831 0.85 L3MBTL1 (0.50) ADORA3MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL3163147 0.84 ALDH1A1 (0.50) ADORA3MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL3172697 0.83 NPC1 (0.47) ADORA3MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL3175775 0.83 ADORA3 (0.48) ADORA3MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL3165534 0.83 ADORA3 (0.44) ADORA3MEN1KMT2ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed